![Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-020-06738-z/MediaObjects/12885_2020_6738_Fig4_HTML.png)
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma | Haematologica
![The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11060-019-03137-8/MediaObjects/11060_2019_3137_Fig3_HTML.png)
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
![A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram](https://www.researchgate.net/publication/365803584/figure/fig2/AS:11431281103691056@1669778461912/A-Cumulative-of-overall-survival-over-28days-between-severe-patients-with-corticosteroid.png)
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
![Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram](https://www.researchgate.net/publication/373951726/figure/fig3/AS:11431281188951526@1694830966860/Overall-survival-from-date-of-LMD-relapse-Median-survival-39-days-95-CI-19-107.png)
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
![The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health](https://www.thelancet.com/cms/asset/c4299591-fd0f-4d45-ab8d-1962047ec582/gr1.jpg)
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health
![Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-023-00823-5/MediaObjects/41571_2023_823_Fig1_HTML.png)
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
![Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-020-06738-z/MediaObjects/12885_2020_6738_Fig3_HTML.png)
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
![Overall survival curve for the “all taxa” data set (Kaplan-Meier estimate and corresponding 95% confidence intervals; N = 4447; the length of time axis is limited to a maximum of 15 days). Overall survival curve for the “all taxa” data set (Kaplan-Meier estimate and corresponding 95% confidence intervals; N = 4447; the length of time axis is limited to a maximum of 15 days).](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/730833/preview.jpg)
Overall survival curve for the “all taxa” data set (Kaplan-Meier estimate and corresponding 95% confidence intervals; N = 4447; the length of time axis is limited to a maximum of 15 days).
![Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab | Anticancer Research Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/42/3/1535/F1.large.jpg)
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab | Anticancer Research
![Long-term survival and quality of life after intensive care for patients 80 years of age or older | Annals of Intensive Care | Full Text Long-term survival and quality of life after intensive care for patients 80 years of age or older | Annals of Intensive Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13613-015-0053-0/MediaObjects/13613_2015_53_Fig3_HTML.gif)
Long-term survival and quality of life after intensive care for patients 80 years of age or older | Annals of Intensive Care | Full Text
![High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-01107-y/MediaObjects/41375_2020_1107_Fig1_HTML.png)
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia
![Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health – Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –](https://www.thelancet.com/cms/attachment/7f8ca4e4-a1f7-470f-baca-e75c768839a8/gr1_lrg.jpg)
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
![Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/05/02/2022.05.02.22274571/F2/graphic-7.large.jpg)
Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv
![Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12957-023-03182-8/MediaObjects/12957_2023_3182_Fig2_HTML.png)